However, pathological scoring systems relate almost solely on studies of the primary tumor tissues such as the most prominent predictive markers in breast cancer, the estrogen receptor (ER), the progesterone receptor (PGR) and the erb-b2 receptor tyrosine kinase (HER-2) status. This evidence concerns the gene ESR1 and breast carcinoma.